medRxiv PreprintsInternational5 November 2026
Who leads Marburg virus research? Gender, geography and funding in authorship, 2008 to early 2023: a bibliometric baseline before the 2023-2025 outbreaks
This is an official announcement record
Firsthand records what medRxiv Preprints announced and links to the original. The wording below is theirs, not ours.
Introduction. Between 2023 and 2025, Marburg virus disease reached Equatorial Guinea, Tanzania, Rwanda and Ethiopia for the first time. WHO's 2025 Marburg research priorities make leadership of studies by local scientists a continuing goal. This study describes who led Marburg virus research before these outbreaks. Methods. I analysed 684 English-language Web of Science papers on Marburg virus published from 2008 to February 2023 (5,700 authorships). Gender was inferred from first names with Gender-API, papers about African countries were identified from their text, funders were harmonised by
Read the official announcement
Opens www.medrxiv.org
More from medRxiv Preprints
- Individualised and Time-Dependent Prediction of Recurrence After Colorectal Cancer Liver Metastases Resection6 November 2026
- Beyond Perinatal Mood: Breadth of Psychiatric Symptoms and Delay Discounting as Correlates of Mothers' Relational Reports from Pregnancy Through Adult Children6 November 2026
- Brainstem functional connectivity integrates microbiome-gut-brain signals in healthy older adults: a cross-sectional evaluation and a randomised controlled probiotic trial6 November 2026
- Effect of results-based financing on selected maternal and child health indicators in Mayuge District, Uganda: a comparative interrupted time series analysis6 November 2026
- Multidimensional deprivation and brain health in older adults in rural northern Tanzania: a cross-sectional community-based study6 November 2026
This content is for informational purposes only and is not medical advice. It is not intended to diagnose, treat, cure, or prevent any disease. Consult a healthcare professional before starting any supplement, treatment, or program: especially if you are pregnant, nursing, taking medication, or managing a health condition.